The development of recombinant vaccines for specific immunotherapy of carcinoma represents a novel approach for the treatment of breast cancer and other tumor types. This article reviews the various parameters that should be considered in the development of recombinant vaccines. Several breast cancer associated antigens are also discussed which may provide potential target molecules. The human carcinoembryonic antigen (CEA), which is expressed on approximately 50
作者:J, Schlom;J, Kantor;S, Abrams;K Y, Tsang;D, Panicali;J M, Hamilton
来源:Breast cancer research and treatment 1996 年 38卷 1期